Adjuvant Development for Vaccines and for Autoimmune and Allergic Diseases
This grant opportunity supports the development of vaccine adjuvants that enhance or modify immune responses for use in vaccines against infectious and immune-mediated diseases. The program is focused on improving pre-clinical adjuvant development to increase vaccine efficacy, especially for at-risk groups like children, the elderly, and the immunocompromised. The program allows Fast-Track and…
Fast-Track proposals will be accepted.\nDirect-to-phase II proposals will be accepted.\nNumber of anticipated awards: 1-3\nBudget (total costs):\nPhase I: $300,000 per year for up to 2 years\nPhase II: $1,000,000 per year with appropriate justification by the applicant for up to 3 years\nBackgro…
Funding Source
Dates
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers